(Q40519641)

21 September 2017

title

Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus (English)

1 reference

Rosetta Martiniello-Wilks

21 September 2017

author

object named as

R Martiniello-Wilks

2

0 references

author name string

X Y Wang

1

1 reference

21 September 2017

J M Shaw

3

1 reference

21 September 2017

T Ho

4

1 reference

21 September 2017

N Coulston

5

1 reference

21 September 2017

C Cooke-Yarborough

6

1 reference

21 September 2017

P L Molloy

7

1 reference

21 September 2017

F Cameron

8

1 reference

21 September 2017

M Moghaddam

9

1 reference

21 September 2017

T J Lockett

10

1 reference

21 September 2017

L K Webster

11

1 reference

21 September 2017

I K Smith

12

1 reference

21 September 2017

G W Both

13

1 reference

21 September 2017

P J Russell

14

1 reference

21 September 2017

publication date

1 November 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

21

1 reference

21 September 2017

page(s)

1559-1567

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302308

21 September 2017

exact match

0 references

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Gene expression by atypical recombinant ovine adenovirus vectors during abortive infection of human and animal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional E1A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Transcription-targeted gene therapy for androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Tissue-specific promoters in gene therapy for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Adenovirus vectors for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

p53 oncogene mutations in three human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression. a review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Construction, Rescue, and Characterization of Vectors Derived from Ovine Atadenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Construction and transfection of ovine adenovirus genomic clones to rescue modified viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

7 January 2021

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

7 January 2021

Transduction of biopsy samples: bridging gene therapy between animals and humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

7 January 2021

Characterisation of Australian ovine adenovirus isolates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

7 January 2021

A transfection compound series based on a versatile Tris linkage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302308

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302308

1 reference

Dimensions Publication ID

21 September 2017

1051293534

0 references

1 reference